title: Africa: children's access to prophylaxis may improve after medical study, new WHO recommendations.
abstract: On November 22, 2004, days after The Lancet reported that the cheap antibiotic co-trimoxazole (Septra, Bactrim, and other brand names) had dramatically reduced death in a group of Zambian children with HIV, the World Health Organization (WHO), UNAIDS and UNICEF released a statement recommending the drug for all children with HIV symptoms in poor countries. But activists say the global health authorities' seemingly quick action came years--even decades--late, and it will take a lot more work to actually deliver the drug's lifesaving promise.
authors.forename: Suzy
authors.initials: S
authors.lastname: Subways
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000349:Africa; D002648:Child; D017408:Guidelines as Topic; D006297:Health Services Accessibility; D006801:Humans; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014944:World Health Organization
chemical_list: D015662:Trimethoprim, Sulfamethoxazole Drug Combination